Document 0603
 DOCN  M9490603
 TI    Intravenous foscarnet administration for treatment of cytomegalovirus
       retinitis.
 DT    9411
 AU    Greening JG
 SO    J Intraven Nurs. 1994 Mar-Apr;17(2):74-7. Unique Identifier : AIDSLINE
       MED/94343129
 AB    Cytomegalovirus (CMV) causes serious infections, particularly
       vision-threatening retinitis, in persons with acquired immune deficiency
       syndrome. Foscarnet has been demonstrated to delay the progression of
       CMV retinitis and is an alternative to ganciclovir. Adverse reactions to
       foscarnet include nephrotoxicity and hypocalcemia and can impact the
       patient's ability to tolerate treatment. Nursing implications and
       interventions essential in helping the patient achieve an optimal
       outcome also are presented.
 DE    AIDS-Related Opportunistic Infections/*DRUG THERAPY/NURSING
       Cytomegalovirus Retinitis/*DRUG THERAPY/NURSING  Foscarnet/*THERAPEUTIC
       USE  Human  Infusions, Intravenous  *Patient Care Planning  JOURNAL
       ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).